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Abstract
Background Little data are available for non-abscess abdominal fluid collections (AFCs) after pancreatic surgery and their
clinical implications. We sought to analyze the natural history of such collections in a population of patients subject to routine
postoperative imaging.
Methods From 1995 to 2011, 709 patients underwent pancreatic resections and routine postoperative monitoring with
abdominal ultrasound according to a unit protocol. AFCs were classified as asymptomatic (no interventional treatment),
symptomatic (need for percutaneous drainage of sterile, amylase-poor fluid), and pancreatic fistula (drainage of
amylase-rich fluid).
Results Ninety-seven of 149 AFCs (65 %) were asymptomatic and resolved spontaneously after a median follow-up of
22 days (interquartile range, 9–52 days). Among 52 (35 %) AFCs requiring percutaneous drainage, there were 20 pancreatic
fistulas and 32 symptomatic collections. A stepwise logistic regression model identified three factors associated with the need
for interventional treatment, i.e., body mass index ≥25 (odds ratio, 3.23; 95 % confidence interval (CI), 1.32 to 7.91),
pancreatic fistula (odds ratio, 2.93; 95 % CI, 1.20 to 7.17), and biliary fistula (odds ratio, 3.92; 95 % CI, 1.35 to 11.31).
Conclusions One fourth of patients develop various types of non-abscess AFCs after pancreatic surgery. Around half of them
are asymptomatic and resolve spontaneously.
Keywords Pancreaticoduodenectomy . Pancreatectomy .
Distal pancreatectomy . Complications . Abdominal fluid
collections
Introduction
The marked decrease in postoperative mortality reported
over recent decades for pancreatic resections is not
paralleled by significant changes in morbidity rates.1,2
Various types of fluid collections within the abdomen re-
main among the most common complications of pancreatic
surgery as no effective prophylaxis is available despite
many technical and pharmacological attempts.
In more recent series, the incidence of intra-abdominal
abscesses following pancreatic resections ranges from 6 to
11 %.3–6 However, little is known about non-abscess ab-
dominal fluid collections (AFCs). Such findings, as gener-
ally believed, are relatively common in the early
postoperative course of patients subject to pancreatic sur-
gery and often resolve spontaneously.7,8 Nevertheless, there
is little evidence to support such claims as AFCs are rarely
reported even in randomized clinical trials focused on the
technical aspects of pancreatectomy.2,9–11 This is partly
related to the retrospective design of most studies on
complications associated with pancreatic surgery and
lack of routine postoperative abdominal imaging in
asymptomatic patients. Consequently, many aspects related
to the natural history of AFCs remain to be clarified to provide
information useful for clinical decision making in the early
postoperative period.12–16
Since 1990, data of all patients undergoing pancreatic
surgery at our academic tertiary surgical center have been
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documented prospectively in a computerized database.
Moreover, all patients are subject to routine abdominal
ultrasound (US) before drain removal and at follow-up
visits. Such a unit protocol allows for early identification
and monitoring of potential abdominal complications in
otherwise asymptomatic patients. Given the paucity of pub-
lished data on non-abscess abdominal collections after pan-
creatic surgery, the aim of this study was to analyze the
natural history of AFCs and identify risk factors predicting
the need for interventional treatment of such collections.
Methods
Patients and Perioperative Care
An electronic database of all patients undergoing pancreatic
resections between 1990 and 2011 at our academic tertiary
surgical center was reviewed. All relevant data, including
demographics, clinical findings, details of surgical proce-
dures, and histopathological parameters, were collected pro-
spectively using a standardized form. The present study was
limited to the period of 1995 through 2011 when results of
routine imaging tests were incorporated in the database. The
study was approved by the Bioethics Committee of
Jagiellonian University.
All procedures were carried out by four senior consultant
surgeons experienced in pancreatobiliary surgery and using
a similar technique of dissection. Technical variations of
pancreatic resections, e.g., pylorus preservation, types of
pancreatic anastomosis, extent of lymphadenectomy, were
performed according to the surgeons’ preferences and clas-
sified as defined by the recent guidelines.17 Abdominal
drains were routinely used and typically removed on post-
operative day (POD) 4 to 5 if daily drainage was <50 ml of
unsuspected effluent with low amylase content. Patients
received perioperative antibiotic prophylaxis, most com-
monly first-generation and second-generation cephalospo-
rins, and low-molecular-weight heparin was used to
minimize the risk of thromboembolic events. Postoperative
analgesia was provided by epidural infusion of bupivacaine
and fentanyl combined with intravenous morphine chloride
and nonsteroidal anti-inflammatory drugs as required.
Prophylactic octreotide was used under surgeon’s discretion
in a dose of 100 μg s.c. starting before surgery and followed
up every 8 h for 5 days. As a unit protocol, abdominal US
was carried out in all patients prior to drain removal (POD 4
to 5) and immediately before discharge. US and/or comput-
ed tomography (CT) were also performed in any patient
with laboratory abnormalities (raised total white blood cell
[WBC] count and increased C-reactive protein or
procalcitonin levels), fever, or abdominal discomfort.
Follow-up examinations were carried out as clinically
required and included routine US in all patients 1 to 2 weeks
after discharge.
Postoperative Complications
All deviations from the normal postoperative course were
recorded and prospectively verified by a pancreatic research
fellow (M.S.). Major surgical complications were classified
according to the current definitions, i.e., postoperative pan-
creatic fistula (POPF: drain output of any measurable vol-
ume of fluid on or after POD 3 with an amylase content
greater than three times the serum amylase activity),18 de-
layed gastric emptying (inability to return to a standard diet
by the end of the first postoperative week with prolonged
nasogastric intubation),19 postpancreatectomy hemorrhage
(evidence of blood loss from drains, nasogastric tube, or
on ultrasonography associated with a decrease in hemoglobin
concentration).20 Bile leak was defined as bilious abdominal
drainage confirmed by a contrast study through an abdominal
drain or cholangiography.21 Abdominal abscess was defined as
collection of fluid diagnosed with US/CT and positive cultures
obtained by percutaneous drainage or at reoperation, regardless
of amylase content.22 Non-abscess AFC was defined as a
collection of fluid measuring ≥3 cm in diameter demonstrated
by transabdominal US or CT scan.9 Asymptomatic AFCs were
followed up with US/CT until spontaneous resolution. AFCs
associated with clinical (abdominal discomfort and fever) or
laboratory abnormalities (high WBC count and increased C-
reactive protein or procalcitonin levels) were drained under US
guidance, and aspirated fluid was sent for culture and amylase
assay. Sterile collections of amylase-rich fluid were classified as
POPFs and those with low amylase content were reported as
symptomatic AFCs. Other surgical and medical complications
were defined as previously described.23 Operative mortality
was defined as any in-hospital death or death occurring within
30 days from surgery.
Statistical Analysis
The differences in proportions between groups were evaluated
using the chi-square test, and theMann–WhitneyU test was used
to detect differences in quantitative variables. Potential risk fac-
tors for AFCs requiring interventional treatment were evaluated
by univariate analysis using cross-tabulations and a stepwise
logistic regression model. The following factors were analyzed:
sex, age (≤65 vs >65 years), American Society ofAnesthesiology
(ASA) physical status (1–2 vs 3–4), diagnosis (benign vs malig-
nant), preexisting diseases (no vs yes), body mass index (BMI
<25 vs ≥25), preoperative body weight loss (<10 vs ≥10 %),
preoperative albumin level (<35 vs ≥35 g/dl), preoperative bili-
rubin level (<30 vs ≥30 μmol/L), preoperative biliary drainage
(no vs yes), type of resection (pancreaticoduodenectomy, distal
pancreatectomy, total pancreatectomy, and other), lymph node
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dissection (standard vs extended), operative time (≤300
vs >300 min), use of somatostatin analogs (no vs yes), need for
autologous blood transfusion (no vs yes), pancreatic gland tex-
ture (hard vs soft), pancreatic fistula (no vs yes), biliary fistula (no
vs yes), and enteric fistula (no vs yes). Significance level
(P) <0.05 was considered statistically significant in a two-tailed
analysis. Statistical analysis was performed using the IBM SPSS
v.20 (SPSS Inc., Chicago, IL, USA) software package.
Results
Postoperative Complications
A total of 718 patients who underwent pancreatic resections
were identified in the database between 1995 and 2011.
Details of routine US imaging were available in 709 cases,
and this group constituted the final study population
(Table 1). There were 373 males and 336 females, with a
median age of 59 years (range, 21 to 83 years). No
neoadjuvant therapy was used for patients with preopera-
tively verified malignancy. The overall morbidity rate was
46 % (326 of 709 patients), with surgical and nonsurgical
complications diagnosed in 31 and 27 % of patients, respec-
tively (Table 2). Reoperation was required in 57 (8 %) cases,
including abdominal abscess (n=24), abdominal bleeding
(n=22), wound dehiscence (n=6), and other (n=5). The
median postoperative hospital stay was 22 days
(interquartile range (IQR), 14–34 days) and was significant-
ly (P<0.001) longer in patients who developed complica-
tions (median, 28 days; IQR, 18–40 days) than for
uneventful recovery (median, 12 days; IQR, 10–15 days).
Thirty-one (4 %) patients died postoperatively.
Abdominal Fluid Collections
There were 149 (21 %) non-abscess AFCs, including 135
adjacent to the pancreatic remnant or in the bed of the resected
pancreas and 14 distant collections. The median time from
surgery to the diagnosis of AFCs was 7 days (IQR, 5–11 days;
Fig. 1), and their median diameter was 6 cm (IQR, 4.5–7.0 cm).
Table 1 Patient demographics and clinicopathological parameters
Age, years, median (IQR) 59 (48–66)
Female/male, n (%) 336 (47)/373 (53)
Diagnosis, n (%)
Pancreatic cancer 300 (42)
Ampullary cancer 150 (21)
Chronic pancreatitis 93 (13)
Endocrine tumors 55 (8)





Diabetes mellitus 97 (14)
ASA physical status (1–2/3–4) 489/220
BMI, median (IQR) 23.5 (21.2–26.5)
Serum albumin, g/dl, median (IQR) 40 (37–44)
Serum bilirubin, μmol/L, median (IQR) 15 (8–41)
Preoperative biliary drainage, n (%) 101 (14)
Procedure, n (%)
Pancreaticoduodenectomy (PD) 253 (36)
Pylorus-preserving PD 153 (22)
Distal pancreatectomy 188 (27)
Total pancreatectomy 85 (12)
Segmental resection 11 (2)
Enucleation 19 (3)
Values in parentheses are percentages (unless indicated)
IQR interquartile range
a Ischemic heart disease, arrhythmia, previous myocardial infarction,
and coronary artery disease
b Asthma and chronic obstructive pulmonary disease
Table 2 Morbidity and mortality rates in 709 patients
Complications No. (percent) of patients
Any complication 326 (46)
Surgical complications 219 (31)
Abdominal fluid collection 149 (21)
Pancreatic fistula 140 (20)
Delayed gastric emptying 60 (8)
Wound infection 54 (8)
Intra-abdominal abscess 43 (6)
Abdominal bleeding 31 (4)
Enteric fistula 21 (3)
Biliary fistula 17 (2)
Gastrointestinal bleeding 12 (2)
Acute pancreatitis 14 (2)
Wound dehiscence 6 (1)
Ileus 3 (1)
Nonsurgical complications 188 (27)
Pneumonia 148 (21)
Sepsis 47 (7)
Pulmonary embolism 35 (5)
Cardiocirculatory failure 32 (5)
Renal failure 28 (4)
Urinary infection 23 (3)
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The proportion of patients diagnosed with early (≤POD 7) and
late (after POD 7) AFCs was similar for symptomatic (50 vs
50 %) and asymptomatic (55 vs 45 %) collections (Fig. 2).
Collections defined as POPF were more common in the early
postoperative period (70 vs 30 %), but the difference was statis-
tically insignificant (P=0.163). The median time to drain remov-
al was 8 days (IQR, 5–12 days) and was significantly (P=0.010)
longer for patients with AFCs (14 days; IQR, 10–24 days) than
Fig. 1 Time elapsed from
surgery to the diagnosis of AFC
Fig. 2 Types of AFCs in relation to time. POD postoperative day
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without collections (5 days; IQR, 4–8 days). The proportion of
patients who develop AFCs after drain removal was higher for
collections defined as symptomatic (53 %) and POPF (75 %).
However, asymptomatic collections were diagnosed more com-
monly before drain removal (59 %). Ninety-seven of 149 AFCs
(65 %) were asymptomatic and resolved spontaneously after a
median follow-up of 22 days (IQR, 9–52 days). Fifty-two (35%)
AFCs required percutaneous drainage after a median time from
diagnosis of 8 days (IQR, 4–19 days). The median time from
drainage to resolution of AFCs was 25 days (IQR, 6–78 days).
Four patients required additional percutaneous interventions for
new or recurrent fluid collections, and five were reoperated on
due to persistent symptomatic AFCs. There were no drainage-
related complications. Hospital readmission related to collection
was required in 27 patients (4 %) (Table 3).
Risk Factors for Fluid Collections Requiring Interventional
Treatment
Univariate analysis of potential risk factors associated with
the need for percutaneous drainage of AFCs is summarized
in Table 4. Subsequent regression analysis (Table 5) of those
variables that significantly affected the rate of interventional
treatment in the univariate analysis identified three factors
increasing the risk for drainage, i.e., BMI ≥25 (odds ratio,
3.23; 95 % confidence interval (CI), 1.32 to 7.91), pancre-
atic fistula (odds ratio, 2.93; 95 % CI, 1.20 to 7.17), and
biliary fistula (odds ratio, 3.92; 95 % CI, 1.35 to 11.31).
Discussion
Surgical complications associated with pancreatic surgery
have gained much attention over the recent years. Various
aspects of POPF, delayed gastric emptying, abdominal
bleeding, and abscesses were extensively analyzed, includ-
ing recommendations for appropriate diagnosis and severity
assessment.18–20 In contrast, little data are available for
asymptomatic non-abscess AFCs and their clinical
implications. Therefore, we sought to analyze the natural
history of such collections in a population of patients subject
to routine postoperative imaging. This study demonstrated
that about 14 % of patients after pancreatic resections de-
veloped transient AFCs that eventually resolved spontane-
ously without any intervention and a further 8 % required
percutaneous drainage for symptomatic collections. The
need for percutaneous drainage was significantly increased
among patients with high BMI and by coexisting pancreatic
or biliary fistula.
Previous reports suggested that the incidence of AFCs
varies from 4 to 30 %.13,24–28 However, such numbers
derived from retrospective studies are inherently biased by
the fact that imaging tests are carried out only in patients
with symptoms suggestive of intra-abdominal complica-
tions. Only a few studies provided some limited data from
prospective observations. In the study of Bassi et al. using
routine US imaging, 17 of 114 (15 %) patients were diag-
nosed with fluid collections <5 cm in diameter on POD 3
after pancreaticoduodenectomy or distal pancreatectomy.9
In another report, 30 of 50 (60 %) patients subject to
pancreaticoduodenectomy with a soft pancreas had AFCs
on POD 7 diagnosed with routine CT scans.29 Nevertheless,
neither of these reports provided information on the actual
nature of such collections or their natural history. In the
present study, 97 of 709 (14 %) patients monitored with
routine postoperative US developed asymptomatic AFCs
that regressed spontaneously after a median follow-up of
22 days. Another 52 (8 %) patients had fluid collections
requiring percutaneous drainage, and the need for interven-
tional treatment was significantly associated with high BMI,
pancreatic fistula, and biliary fistula with odds ratios of
about 3.
The incidence rate of intra-abdominal collections associ-
ated with POPF ranges from 20 to 81 % and is markedly
higher in patients with fistula grades B and C.30–33 In this
study, the proportion of asymptomatic collections was sim-
ilar in patients with and without pancreatic fistula (14 vs
13 %, P=0.816), and the median time to their resolution was










Total (n=709) P valuea
Abscess 24 (6) 9 (5) 7 (8) 3 (10) 43 (6) 0.552
Pancreatic fistula (POPF) 15 (4) 3 (2) 0 (0) 2 (7) 20 (3) 0.031
Symptomatic AFCs 16 (4) 11 (6) 3 (4) 2 (7) 32 (5) 0.820
Asymptomatic AFCs 50 (12) 34 (18) 10 (12) 3 (10) 97 (14) 0.366
Values in parentheses are percentages
POPF postoperative pancreatic fistula, AFCs abdominal fluid collections
a Chi-square test
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comparable (17 vs 23 days, P=0.668). However, the pro-
portion of patients with symptomatic collections requiring
drainage was significantly higher (14 vs 6 %, P<0.001), and
all of them were verified as POPF due to high amylase
content. This suggests that asymptomatic AFCs do not
always require interventional treatment in a patient with
POPF. Such an opinion is supported by observations made
by Pratt et al. who reported percutaneous drainage only in
14 of 34 patients with POPF grades B and C and fluid
collections after various pancreatic resections.33
Data for the impact of biliary fistulas on abdominal
complications after pancreatic surgery are scarce. The larg-
est study, of Burkhart et al., reported hepaticojejunostomy
leaks after pancreaticoduodenectomy in 16 of 715 patients
(2.2 %).21 Leaks were significantly associated with pancre-
atic fistula (50 vs 12 %, P<0.001), wound infection (38 vs
8 %, P=0.003), delayed gastric emptying (31 vs 10 %, P=
0.036), and sepsis (31 vs 3 %, P<0.001). However, the
authors provided no information about abdominal collec-
tions. Another retrospective analysis of 149 patients subject
to pancreatoduodenectomy revealed that early (≤7 days
postoperatively) collections were associated with either
Table 4 Univariate analysis of risk factors for non-abscess abdominal
collections requiring percutaneous drainage (chi-square test)
Factor Abdominal fluid collections requiring
drainage
Yes (n=52) No (n=97) P value
Age (years) 0.944
≤65 41 (79) 76 (78)
>65 11 (21) 21 (22)
Gender 0.496
Female 25 (48) 41 (42)
Male 27 (52) 56 (58)
Diagnosis 0.716
Benign 12 (23) 25 (26)
Malignant 40 (77) 72 (74)
Comorbidities 0.350
No 23 (44) 41 (42)
Yes 29 (56) 56 (58)
ASA physical status 0.791
1 or 2 37 (71) 67 (69)
3 or 4 15 (29) 30 (31)
BMI 0.047
<25 31 (60) 73 (75)
≥25 21 (40) 24 (25)
Body weight loss >10 % 0.107
No 37 (71) 56 (58)
Yes 15 (29) 41 (42)
Albumin, g/dl 0.409
≤35 9 (17) 12 (12)
>35 43 (83) 85 (88)
Bilirubin, μmol/L 0.357
≤30 44 (85) 76 (78)
>30 8 (15) 21 (22)
Preoperative biliary drainage 0.917
No 39 (75) 72 (74)
Yes 13 (25) 25 (26)
Procedure 0.279
Pancreaticoduodenectomy 31 (60) 50 (52)
Distal pancreatectomy 14 (27) 34 (35)
Total pancreatectomy 3 (6) 10 (10)
Other 4 (7) 3 (3)
Operative time (min) 0.275
≤300 29 (56) 45 (46)
>300 23 (44) 52 (54)
Lymph node dissection 0.362
Standard 34 (65) 56 (58)
Extended 18 (35) 41 (42)
Pancreatic gland texture 0.219
Hard 11 (21) 13 (13)
Soft 41 (79) 84 (87)
Somatostatin use 0.105
No 17 (33) 45 (46)
Yes 35 (67) 52 (54)
Need for blood transfusion 0.079
No 19 (37) 50 (52)
Yes 33 (63) 47 (48)
Table 4 (continued)
Factor Abdominal fluid collections requiring
drainage
Yes (n=52) No (n=97) P value
Pancreatic fistula 0.005
No 30 (58) 77 (79)
Yes 22 (42) 20 (21)
Biliary fistula 0.006
No 44 (85) 94 (97)
Yes 8 (15) 3 (3)
Enteric fistula 0.477
No 51 (98) 93 (96)
Yes 1 (2) 4 (4)
Table 5 Multivariable logistic regression analysis of risk factors for
non-abscess abdominal collections requiring percutaneous drainage
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pancreatic anastomotic or biliary leaks.13 Nevertheless, any
formal analysis of such an association for biliary fistula was
not possible due to very small sample size, i.e., only three
patients with biliary leaks.
The only preoperative factor significantly associated in this
study with the need for interventional treatment of AFCs was
BMI ≥25. A supplementary analysis failed to confirm such a
relationship with other abdominal complications, including
asymptomatic AFCs and POPF (data not shown). This corre-
lation is somehow controversial not only for pancreatic surgery
but also for other types of abdominal surgery.34 A recent meta-
analysis of 17 studies and a total of 4,045 patients showed no
definitive detrimental effects of overweight/obesity on postop-
erative outcomes, with only four studies reporting higher rates
of POPF (odds ratio range, 1.6–4.2).35 In fact, even those
studies suggesting increased morbidity rates among patients
with high BMI provided no detailed data necessary to establish
a potential association between overweight and various types of
abdominal collections.
The present analysis has some inherent limitations. First,
we used abdominal US for screening of asymptomatic pa-
tients, and this could underestimate rates of fluid collections
compared to CT. The operator-dependent characteristics of
such imaging must be taken into account, though; all exam-
inations were carried out by surgeons acquainted with US
assessment of patients following abdominal surgery and a
caseload of about 1,000 per year. Second, asymptomatic
collections were not verified by percutaneous aspiration,
and this may raise the question about their actual nature.
However, such collections were evenly distributed among
patients with pancreatic, biliary, and enteric fistulas, and
time to their resolution was not affected by these complica-
tions. This provides some evidence that asymptomatic col-
lections were most probably unrelated to other abdominal
complications. Third, we could not examine the correlation
between drain removal and fluid collections as drains were
routinely removed on POD 4 to 5 after US excluded poten-
tial abdominal complications. Therefore, prolonged drain-
age in our case was a consequence of abnormal recovery
based on US or clinical findings. Some previous studies
suggested that early drain removal (POD 3 or 4) is superior
to prolonged drainage (POD 5 or 8) in terms of reduced rates
of abdominal complications.9,11 Similar benefits were dem-
onstrated by a retrospective cohort study in patients without
routine abdominal drainage.36 However, the latter group
published earlier the only existing randomized clinical trial
on routine intraperitoneal drainage after pancreatic resec-
tions and failed to demonstrate significant differences in
the incidence of abdominal collections (6.8 vs 2.2 % in
drained and not drained group, respectively) or abscesses
(6.8 vs 6.6 %).10 Therefore, the question of whether routine
drainage increases the risk of abdominal collections in pan-
creatic surgery remains unanswered.
Conclusion
In conclusion, this study demonstrated that approximately one
fourth of patients develop various types of AFCs after pan-
creatic surgery. About half of them are asymptomatic and
resolve spontaneously. However, collections associated with
pancreatic and biliary fistulas, as well as those in patients with
high BMI, are likely to require interventional treatment.
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